Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Pharmaceutical Caps and Closures Market 2016-2020 - Increased Demand for Innovative Designs With Amcor, Caps & Closures, O.Berk, Closure Systems International & Global Closure System Dominating - Research and Markets

Research and Markets
Posted on: 02 Sep 16

Research and Markets has announced the addition of the "Global Pharmaceutical Caps and Closures Market 2016-2020" report to their offering.

The global pharmaceuticals caps and closures market to grow at a CAGR of 5.36% during the period 2016-2020.

Pharmaceutical caps and closures protect complex pharmaceuticals so that they remain safe and secure, devoid of any contamination. Drug manufacturers are bound by international compliance jurisdictions enforced by regulatory authorities, which ensure packaging is a critical element in the drug delivery process to the final point of purchase. Various raw materials like plastic resins, rubber, and aluminum find application in the production of pharmaceutical caps and closures.

The report covers the present scenario and the growth prospects of the global pharmaceuticals caps and closures market for 2016-2020. To calculate the market size, the report presents the vendor landscape and a corresponding detailed analysis of the top five vendors operating in the market.

Emergence of dual-spout closures will be a key trend for market growth. Consumer convenience has become the key element for all the innovations in the global pharmaceutical market. Companies are introducing advance designs, which entice the consumer by the type of convenience it provides. For instance, Triumph Pharmaceutical has also launched dual spout closures for its oral care product SmartMouth. It allows the consumer to use two solutions simultaneously from two bottles packed as one. This product comes in three categories: original, gum and plaque, and dry mouth. The two PET bottles are together by one closure and is fully shrink-wrapped. Consumer can mix two solutions together, before dispensing the liquid out of a bottle.

According to the report, one of the key drivers for market growth will be replacement of one-piece over two-piece caps. Most companies use injection-molded HDPE closures for packaging pharma products. They are commonly used in Europe and Asia, and still growing in other part of the world. Shifting from two-piece closures to one-piece closures require changes in material as well as the manufacturing process. Single-piece caps reduce the material used and the weight of overall packaging. Single-piece closures weigh 2 grams less than the two-piece caps and closures. They also have other features such as a large seal angle and require less torque. They reduce resin consumption by 6 tons and carbon footprint by approximately more than 15 tons per 500 million bottles.

Further, the report states that incompatibility of plastic polymers with substrates will be a challenge for the market. Plastic has become a principle material for manufacturing caps and closure for pharmaceutical products. Polyethylene and polypropylene are incompatible with certain organic liquids and mineral acids on account of their chemical properties and this often leads to deformation of the packaging substrate or may adulterate the product.

Key vendors

  • Amcor
  • Caps & Closures
  • O.Berk
  • Closure Systems International
  • Global Closure Systems

Other prominent vendors

  • Alpha Packaging
  • Guala Closures
  • Mocap
  • Phoenix closures
  • Reynold
  • Technocap
  • WestRock

For more information about this report visit

Related Topics: Beverage Packaging

View source version on

Business Wire

Last updated on: 02/09/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.